Homepage
Open in app
Sign in
Get started
Lazarus AI
Lazarus applies AI and computer vision to develop products and custom solutions to optimize process
Follow
Latest
Trending
Jessica Pyhtila
in
Lazarus AI
Mar 10, 2022
FDA Approves Combination Treatment for BPH Symptoms
Read more…
1
Jessica Pyhtila
in
Lazarus AI
Feb 17, 2022
FDA Approves New Orally Disintegrating Dosage Form of Glycopyrrolate
Read more…
2
Jessica Pyhtila
in
Lazarus AI
Jan 31, 2022
FDA Approves Novel PCSK9 Inhibitor Inclisiran (Leqvio)
Read more…
Manijeh “Mani” Berenji MD MPH
in
Lazarus AI
Jan 5, 2022
Evaluating the Effectiveness of Biologic Agents for Metastatic Colon Cancer among Black and White Americans: A Study…
Read more…
1
Jessica Pyhtila
in
Lazarus AI
Dec 28, 2021
FDA Approves Rivaroxaban in an Oral Suspension Dosage Form
Read more…
2
Manijeh “Mani” Berenji MD MPH
in
Lazarus AI
Dec 20, 2021
Adverse Pregnancy Outcomes and Incident Heart Failure in the Women’s Health Initiative: A Review
Read more…
1
Manijeh “Mani” Berenji MD MPH
in
Lazarus AI
Dec 13, 2021
Risk of Guillain-Barré in Recipients of the Zoster Recombinant Vaccine Shingrix: Review of a Case Series Cohort Study
Read more…
Manijeh “Mani” Berenji MD MPH
in
Lazarus AI
Dec 6, 2021
Osteoarthritis and Use of Non-Steroidal Anti-Inflammatories: The Latest Analysis
Read more…
Jessica Pyhtila
in
Lazarus AI
Oct 12, 2021
FDA Approves Atogepant As Newest CGRP Antagonist for Migraine Prevention
Read more…
Jessica Pyhtila
in
Lazarus AI
Oct 7, 2021
FDA Approves Ergot-Derivative Nasal Spray to Treat Acute Migraine
Read more…
10
About
Lazarus AI
Lazarus applies AI and computer vision to develop products and custom solutions to optimize process
More information
Followers
19
Elsewhere
